Abstract
The interest in tumor-associated glycoconjugate antigens was particularly initiated by Springer, who published in 1984 that glycoproteins on the outer cell-membrane of epithelial tumor cells have an altered glycosylation consisting of the Thomsen-Friedenreich (T-) antigen and its precursor the TN-antigen structure (Springer 1984). He and his coworkers also had found that monoclonal antibodies induced with glycoproteins from tumor cell membranes showed cross-reactivity to desialylated glycophorin A. It was concluded from these observations that the T-and TN-glycoproteins on the epithelial tumor cells must be structurally related to asialoglycophorin A (Springer et al. 1983) (Fig. 11.1a). Glycophorin A is the major sialoglycoprotein on erythrocytes. In the N-terminal domain it contains cryptic T-antigen structures which are covered by sialylation in the 3′- and 6-position. The glycophorin exists in two blood group specificities M and N, which have identical glycoforms, but differ in two of the total 131 amino acids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Backes BJ, Virgilio AA, Ellman JA (1996) Activation method to prepare a highly reactive acylsulfonamide “Safety-Catch” linker for solid-phase synthesis. J Am Chem Soc 118:3055–3056
Bardaji E, Torres JL, Clapes P, Albericio F, Barany G, Rodriguez RE (1991) Synthesis and biological activity of O-glycosylated morphiceptin analogs. J Chem Soc Perkin Trans 1:1755
Becker T, Dziadek S, Wittrock S, Kunz H (2006) Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy. Curr Cancer Drug Targets 6:491–517
Becker T, Kaiser A, Kunz H (2009) Synthesis of dendrimeric tumor-associated mucin-type glycopeptide antigens. 2009:1113–1122
Bessler WG, Heinewetter L, Wiesmueller KH, Jung G, Baier W, Huber M, Lorenz AR, van der Esche U, Mittenbuhler K, Hoffman P (1998) Bacterial cell wall components as immunomodulators. 1. Lipopeptides as adjuvants for parenteral and oral immunization. Int J Immunopharmacol 19:547–550
Braccini I, Derouet C, Esnault J, du Penhoat CH, Mallet JM, Michon V, Sinay P (1993) Conformational analysis of nitrilium intermediates in glycosylation reactions. Carbohydr Res 246:23–41
Brockhausen I, Yang JM, Bruchell J, Whitehouse C, Taylor-Papadimitriou J (1995) Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 233:607–17
Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta Gen Subj 1473:67–95
Burchell JM, Mungul A, Taylor-Papadimitriou J (2001) O-linked glycosylation in the mammary gland: changes that occur during malignancy. J Mammary Gland Biol Neoplasia 6:355–64
Carpino LA (1993) 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J Am Chem Soc 115:4397–8
Dasgupta F, Garegg PJ (1988) Use of sulfenyl halides in carbohydrate reactions. Part I. Alkyl sulfenyl triflate as activator in the thioglycoside-mediated formation of β-glycosidic linkages during oligosaccharide synthesis. Carbohydr Res 177:C13–C17
Dourtoglou V, Gross B, Lambropoulou V, Zioudrou C (1984) O-Benzotriazolyl-N,N,N′, N′-tetramethyluronium hexafluorophosphate as coupling reagent for the synthesis of peptides of biological interest. Synthesis 1984:572–4
Frechet JMJ, Haque KE (1975) Polymers as protecting groups in organic synthesis. II. Protection of primary alcohol functional groups. Tetrahedron Lett 16:3055–6
Furuhata K, Komiyama K, Ogura H, Hata T (1991) Studies on sialic acids. Part XXIII. Studies on glycosylation of the mitomycins. Syntheses of 7-N-(4-O-glycosylphenyl)-9a-methoxymitosanes. Chem Pharm Bull 39:255–9
Gendler S, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peal N, Bruchell J, Pemberton L, Lalani EN, Wilson P (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265:15286–15293
Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299
Hanisch F-G (2001) O-glycosylation of the mucin type. Biol Chem 382:143–149
Helferich B, Wedemeyer KF (1949) Preparation of glucosides from acetobromoglucose. Justus Liebigs Ann Chem 563:139–45
Herzner H, Reipen T, Schultz M, Kunz H (2000) Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs. Chem Rev 100:4495–4537
Hoffman-Röder A, Kaiser A, Wagner S, Gaidzik N, Kowalczyk D, Westerlind U, Gerlitzki B, Schmitt E, Kunz H (2010) Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue. Angew Chem Int Ed 4:8498–8503
Ingale S, Buskas T, Boons GJ (2006) Synthesis of glyco(lipo)peptides by liposome-mediated native chemical ligation. Org Lett 8:5785–5788
Ingale S, Wolfert MA, Gaekwad J, Buskas T, Boons GJ (2007) Robust immune responses elicited by a fully synthetic three-component vaccine. Nat Chem Biol 3:663–667
Ingale S, Wolfert MA, Buskas T, Boons GJ (2009) Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors. Chembiochem 10:455–463
Jansson AM, Meldal M, Bock K (1992) Solid-phase synthesis and characterization of O-dimannosylated heptadecapeptide analogues of human insuline-like growth factor 1 (IGF-1). J Chem Soc Perkin Trans 1:1699–1707
Kaiser A, Gaidzik N, Westerlind U, Kowalczyk D, Hobel A, Schmitt E, Kunz H (2009) A synthetic vaccine consisting of a tumor-associated Sialyl-TN-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response. Angew Chem Int Ed 48:7551–7555
Kaiser A, Gaidzik N, Becker T, Menge C, Groh K, Cai H, Li YM, Gerlitzki B, Schmitt E, Kunz H (2010) Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the toll-like receptor 2. Angew Chem Int Ed 49:3688
Keil S, Claus C, Dippold W, Kunz H (2001) Towards the development of antitumor vaccines: a synthetic conjugate of a tumor-associated MUC1 glycopeptide antigen and a tetanus toxin epitope. Angew Chem Int Ed 40:366–369
Keil S, Kaiser A, Syed F, Kunz H (2009) Dendrimers of vaccines consisting of tumor-associated glycopeptide antigens and T cell epitope peptides. Synthesis 2009:1355–1369
Keller O, Rudinger J (1975) Preparation and some properties of maleimido acids and maleoyl derivatives of peptides. Helv Chim Acta 58:531–541
Kihlberg J, Elofsson M (1997) Solid-phase synthesis of glycopeptides: immunological studies with T cell stimulating glycopeptides. Curr Med Chem 4:85–116
Koenigs W, Knorr E (1901) Derivatives of grape sugar and galactose. Ber Dtsch Chem Ges 34:957–981
Kunz H, Birnbach S (1986) Synthesis of tumor associated TN- and T-antigen type O-glycopeptides and their conjugation to bovine serum albumin. Angew Chem Int Ed 25:360–362
Kunz H (1987) Synthesis of glycopeptides, partial structures of biological recognition components. Angew Chem Int Ed 26:294–308
Kunz H, Birnbach S, Wernig P (1990) Synthesis of glycopeptides with the TN and T antigen structures, and their coupling to bovine serum albumin. Carbohydr Res 202:207–23
Kunz H (1997) O- and N-glycopeptides: synthesis of selectively deprotected building blocks. In: Hanessian S (ed) Preparative carbohydrate chemistry. Marcel Dekker, New York, pp 265–281
Lee D, Danishefsky SJ (2009) ‘Biologic’ level structures through chemistry: a total synthesis of a unimolecular pentavalent MUCI glycopeptide construct. Tetrahedron Lett 50:2167–2170
Lemieux RU (1963) Tetra-O-acetyl-d-glucopyranosyl bromide. In: Whistler RL, Wolfrom ML (eds) Methods in carbohydrate chemistry, vol 2. Academic, New York, pp 221–223
Lemieux RU, Ratcliffe RM (1979) The azidonitration of tri-O-acetyl-d-galactal. Can J Chem 57:1244–51
Lergenmüller M, Ito Y, Ogawa T (1998) Use of dichlorophthaloyl (DCPhth) group as an amino protecting group in oligosaccharide synthesis. Tetrahedron 54:1381–1394
Liakatos A, Kunz H (2007) Synthetic glycopeptides for the development of cancer vaccines. Curr Opin Mol Ther 9:35–44
Liebe B, Kunz H (1994) Synthesis of Sialyl-Tn antigen. Regioselective sialylation of a galactosamine threonine conjugate unblocked in the carbohydrate portion. Tetrahedron Lett 35:8777–8
Liebe B, Kunz H (1997a) Solid-phase synthesis of a tumor-associated sialyl-TN antigen glycopeptide with a partial sequence of the “tandem repeat” of the MUC-1 mucin. Angew Chem Int Ed 36:618–621
Liebe B, Kunz H (1997b) Solid-phase synthesis of a sialyl-Tn-glycoundecapeptide of the MUC1 repeating unit. Helv Chim Acta 80:1473–1482
Lloyd KO, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 271:33325–33334
Loenn H, Stenvall K (1992) Exceptionally high yield in glycosylation with sialic acid. Synthesis of a GM3 glycoside. Tetrahedron Lett 33:115–16
Marra A, Sinay P (1989) Stereoselective synthesis of 2-thioglycosides of N-acetylneuraminic acid. Carbohydr Res 187:35–42
Meinjohanns E, Meldal M, Schleyer A, Paulsen H, Bock K (1996) Efficient syntheses of core 1, core 2, core 3 and core 4 building blocks for SPS of mucin O-glycopeptides based on the N-Dts-method. J Chem Soc Perkin Trans 1:985–993
Meldal M (1994) Glycopeptide synthesis. Neoglycoconjugates: Prep Appl 1994:145–98
Paulsen H, Hoelck JP (1982) Building blocks of oligosaccharides. Part XV. Synthesis of O-β-d-galactopyranosyl-(1→3)-O-(α-d-2-acetamido-2-deoxy-α-d-galactopyranosyl)-(1→3)-l-serine and -l-threonine glycopeptides. Carbohydr Res 109:89–107
Peters S, Bielfeldt T, Meldal M, Bock K, Paulsen H (1992) Multiple-column solid-phase glycopeptide synthesis. J Chem Soc Perkin Trans 1:1163–1171
Ragupathi G, Koide F, Livingstone PO, Cho YS, Endo A, Wan Q, Spassova M, Keding S, Allen J, Ouerfelli O, Wilson RM, Danishefsky SJ (2006) Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates. J Am Chem Soc 128:2715–2725
Rosen T, Lico IM, Chu DTW (1988) A convenient and highly chemoselective method for the reductive acetylation of azides. J Org Chem 53:1580–2
Schmidt RR, Behrendt M, Toepfer A (1990) Glycosyl imidates. 48. Nitriles as solvents in glycosylation reactions: highly selective β-glycoside synthesis. Synlett 1990:694–6
Schuster M, Wang P, Paulson JC, Wong CH (1994) Solid-phase chemical-enzymic synthesis of glycopeptides and oligosaccharides. J Am Chem Soc 116:1135–1136
Seitz O, Kunz H (1997) HYCRON, an allylic anchor for high-efficiency solid phase synthesis of protected peptides and glycopeptides. J Org Chem 62:813–826
Shafizadeh F (1963) Galactal. In: Whistler RL, Wolfrom ML (eds) Methods in carbohydrate chemistry, vol 2. Academic, New York, pp 409–410
Shin I, Jung HJ, Lee MR (2001) Chemoselective ligation of maleimidosugars to peptides/protein for the preparation of neoglycopeptides/neoglycoprotein. Tetrahedron Lett 42:1325–1328
Sjölin P, Elofsson M, Khilberg J (1996) Removal of acyl protecting groups from glycopeptides: base does not epimerize peptide stereocenters, and β-elimination is slow. J Org Chem 61:560–565
Smith M, Rammler DH, Goldberg IH, Khorana HG (1962) Polynucleotides. XIV. Specific synthesis of the C3′-C5′ internucleotide linkage. Synthesis of uridylyl(3′→5′)-uridine and uridylyl-(3′→5′)-adenosine. J Am Chem Soc 84:430–40
Sorensen AL, Reis CA, Tarp MA, Mandel U, Ramachandran K, Sankaranarayanan V, Schwientek T, Graham J, Taylor-Papadimitriou J, Hollingsworth MA, Burchell J, Clausen H (2006) Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Glycobiology 16:96–107
Springer GF, Desai RR, Fry WA, Goodale RL, Shearen JG, Scanlon EF (1983) T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses. Cancer Detect Prev 6:111–118
Springer GF (1984) T and Tn, general carcinoma autoantigens. Science 224:1198–206
Swallow DM, Gendler S, Griffiths B, Corney G, Taylor-Papadimitriou J, Bramwell ME (1987) The human tumor-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM. Nature 328:82–4
Tam JP (1988) Methionine ligation strategy in the biomimetic synthesis of parathyroid hormones. Proc Natl Acad Sci USA 85:5409–13
Tarp MA, Sorensen AL, Mandel U, Paulsen H, Burchell J, Taylor-Papadimitriou J, Clausen H (2007) Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat. Glycobiology 17:197–209
Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M (1999) MUC1 and cancer. Biochim Biophys Act, Mol Basis Dis 1455:301–313
Tietze LF, Arlt M, Beller M, Gluesenkamp KH, Jaehde E, Rajewsky MF (1991) Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of the neoglycoprotein in the histochemical detection of lectins. Chem Ber 124:1215–21
Tomita M, Marchesi VF (1975) Amino acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci USA 72:2964–2968
Wagner M, Dziadek S, Kunz H (2003) The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteins. Chem Eur J 9:6018–6030
Wang SS (1973) p-Alkoxybenzyl alcohol resin and p-alkoxybenzyloxycarbonylhydrazide resin for solid phase synthesis of protected peptide fragments. J Am Chem Soc 95:1328–33
Westerlind U, Hobel A, Gaidzik N, Schmitt E, Kunz H (2008) Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response. Angew Chem Int Ed 47:7551–7556
Westerlind U, Schröder H, Hobel A, Gaidzik N, Kaiser A, Niemeyer CM, Schmitt E, Waldmann H, Kunz H (2009) Tumor-associated MUC1 tandem-repeat glycopeptide microarrays to evaluate serum- and monoclonal-antibody specificity. Angew Chem Int Ed 48:8263–8267
Wilkinson BL, Day S, Malins LR, Apostolopoulos V, Payne RJ (2011) Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the toll-like receptor 2 agonist Pam3CysSer. Angew Chem Int Ed 50:1635–1639
Wittrock S, Becker T, Kunz H (2007) Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin. Angew Chem Int Ed 46:5226–5230
Zemplén G, Kuntz A (1923) The sodium compounds of glucose and the saponification of the acylated sugars. Chem Ber 56B:1705–1710
Zhu J, Wan Q, Lee D, Yang G, Spassova M, Ouerfelli O, Ragupathi G, Damani P, Livingstone PO, Danishefsky SJ (2009) From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine. J Am Chem Soc 131:9298–9303
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag/Wien
About this chapter
Cite this chapter
Westerlind, U., Kunz, H. (2012). Antitumor Vaccines Based on Synthetic Mucin Glycopeptides. In: Kosma, P., Müller-Loennies, S. (eds) Anticarbohydrate Antibodies. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0870-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0870-3_11
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0869-7
Online ISBN: 978-3-7091-0870-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)